52 related articles for article (PubMed ID: 17673678)
1. Crosstalk between cytotoxic T-lymphocyte associated antigen-4 and interleukin-12 in cytotoxic T-lymphocyte-mediated myocarditis: adding another link to the chain.
Ahuja SS; Estrada CA; Lindsey ML
Circ Res; 2007 Aug; 101(3):218-20. PubMed ID: 17673678
[No Abstract] [Full Text] [Related]
2. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
[TBL] [Abstract][Full Text] [Related]
3. The reverse stop-signal model for CTLA4 function.
Rudd CE
Nat Rev Immunol; 2008 Feb; 8(2):153-60. PubMed ID: 18219311
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte-associated antigen 4 inhibition increases the antitumor activity of adoptive T-cell therapy when carried out with naïve rather than differentiated T cells.
Ishikawa T; Adachi S; Okayama T; Kokura S; Mizushima K; Doi T; Matsuyama T; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Naito Y; Itoh Y; Yoshikawa T
Oncol Rep; 2015 May; 33(5):2545-52. PubMed ID: 25738564
[TBL] [Abstract][Full Text] [Related]
5. B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.
Gajewski TF
J Immunol; 1996 Jan; 156(2):465-72. PubMed ID: 8543795
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T cells reactive to an immunodominant leukemia-associated antigen can be specifically primed and expanded by combining a specific priming step with nonspecific large-scale expansion.
Ghosh A; Wolenski M; Klein C; Welte K; Blazar BR; Sauer MG
J Immunother; 2008; 31(2):121-31. PubMed ID: 18481382
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion.
Saverino D; Tenca C; Zarcone D; Merlo A; Megiovanni AM; Valle MT; Manca F; Grossi CE; Ciccone E
J Immunol; 1999 Jan; 162(2):651-8. PubMed ID: 9916682
[TBL] [Abstract][Full Text] [Related]
8. Effective priming of cytotoxic T lymphocyte precursors by subcutaneous administration of peptide antigens in liposomes accompanied by anti-CD40 and anti-CTLA-4 antibodies.
Ito D; Ogasawara K; Matsushita K; Morohashi T; Namba K; Matsuki N; Kitaichi N; Inuyama Y; Hosokawa M; Nakayama E; Iwabuchi K; Onoé K
Immunobiology; 2000 Apr; 201(5):527-40. PubMed ID: 10834311
[TBL] [Abstract][Full Text] [Related]
9. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.
Grabie N; Delfs MW; Westrich JR; Love VA; Stavrakis G; Ahmad F; Seidman CE; Seidman JG; Lichtman AH
J Clin Invest; 2003 Mar; 111(5):671-80. PubMed ID: 12618521
[TBL] [Abstract][Full Text] [Related]
10. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.
Sugita S; Streilein JW
J Exp Med; 2003 Jul; 198(1):161-71. PubMed ID: 12835481
[TBL] [Abstract][Full Text] [Related]
11. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells.
Curtsinger JM; Schmidt CS; Mondino A; Lins DC; Kedl RM; Jenkins MK; Mescher MF
J Immunol; 1999 Mar; 162(6):3256-62. PubMed ID: 10092777
[TBL] [Abstract][Full Text] [Related]
13. IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets.
Ye Z; Huang H; Hao S; Xu S; Yu H; Van Den Hurk S; Xiang J
J Interferon Cytokine Res; 2007 Dec; 27(12):1031-8. PubMed ID: 18184044
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils sustain pathogenic CD8+ T cell responses in the heart.
Grabie N; Hsieh DT; Buono C; Westrich JR; Allen JA; Pang H; Stavrakis G; Lichtman AH
Am J Pathol; 2003 Dec; 163(6):2413-20. PubMed ID: 14633613
[TBL] [Abstract][Full Text] [Related]
15. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J; Fujiwara H; Hamaoka T
Cancer Res; 1997 Sep; 57(18):4036-41. PubMed ID: 9307290
[TBL] [Abstract][Full Text] [Related]
16. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
Van Gool SW; de Boer M; Ceuppens JL
J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
[TBL] [Abstract][Full Text] [Related]
17. Regulation of interferon-gamma during the mixed lymphocyte reaction.
Toungouz M; Denys C; Andrien M; Dupont E
Transplant Proc; 1996 Oct; 28(5):2911-2. PubMed ID: 8908120
[No Abstract] [Full Text] [Related]
18. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
Sun JB; Eriksson K; Li BL; Lindblad M; Azem J; Holmgren J
Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
[TBL] [Abstract][Full Text] [Related]
19. T cells down-modulate peptide-MHC complexes on APCs in vivo.
Kedl RM; Schaefer BC; Kappler JW; Marrack P
Nat Immunol; 2002 Jan; 3(1):27-32. PubMed ID: 11731800
[TBL] [Abstract][Full Text] [Related]
20. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
